Published in Exp Eye Res on September 01, 1996
Incidence of contact-lens-associated microbial keratitis and its related morbidity. Lancet (1999) 3.95
Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol (1996) 3.67
Serologic and polymerase chain reaction analysis of intraocular fluids in the diagnosis of infectious uveitis. Am J Ophthalmol (1996) 2.20
Analysis of immunoregulatory cytokines in ocular fluid samples from patients with uveitis. Invest Ophthalmol Vis Sci (1998) 2.07
Uveitis and systemic disease. Br J Ophthalmol (1992) 1.88
Clinical features of acute anterior uveitis. Am J Ophthalmol (1987) 1.66
Association and dissociation of aggregated IgG from rat peritoneal macrophages. J Exp Med (1977) 1.61
Characteristics of soluble immune complexes prepared from oligovalent DNP conjugates and anti-DNP antibodies. J Immunol Methods (1977) 1.59
Expression of multiple cytokines and IL-1RA in the uvea and retina during endotoxin-induced uveitis in the rat. Invest Ophthalmol Vis Sci (1994) 1.40
Anterior uveitis with sectoral iris atrophy in the absence of keratitis: a distinct clinical entity among herpetic eye diseases. Ophthalmology (2000) 1.39
Retinal pigment epithelium-immune system interactions: cytokine production and cytokine-induced changes. Prog Retin Eye Res (2001) 1.38
The influence of phagocyte function on glomerular localization of aggregated IgM in rats. Clin Exp Immunol (1978) 1.38
Aqueous humor interleukin-6 levels in uveitis. Invest Ophthalmol Vis Sci (1990) 1.36
The role of complement in the binding and degradation of immunoglobulin aggregates by macrophages. J Immunol (1979) 1.36
Association of birdshot retinochoroidopathy and HLA-A29 antigen. Curr Eye Res (1990) 1.35
Enhanced degradation of soluble immunoglobulin aggregates by macrophages in the presence of complement. Immunology (1979) 1.35
Serology in ocular toxoplasmosis. Br J Ophthalmol (1986) 1.29
Risk factors for ocular sarcoidosis. Doc Ophthalmol (1989) 1.28
Polarized secretion of IL-6 and IL-8 by human retinal pigment epithelial cells. Clin Exp Immunol (1998) 1.27
Isolation of stable aggregates of IgG by zonal ultracentrifugation in sucrose gradients containing albumin. Immunol Commun (1979) 1.27
Modulation of classical C3 convertase of complement by tear lactoferrin. Immunology (1982) 1.25
The predictive value of serum angiotensin converting enzyme and lysozyme levels in the diagnosis of ocular sarcoidosis. Am J Ophthalmol (1987) 1.24
Kinetics of intraocular tumor necrosis factor and interleukin-6 in endotoxin-induced uveitis in the rat. Invest Ophthalmol Vis Sci (1994) 1.24
Changes in cytokine mRNA levels in experimental corneal allografts after local clodronate-liposome treatment. Invest Ophthalmol Vis Sci (1999) 1.22
Detection of intraocular antibody production to herpesviruses in acute retinal necrosis syndrome. Am J Ophthalmol (1994) 1.21
Cytokines and uveitis, a review. Curr Eye Res (1992) 1.21
T-bet expression is upregulated in active Behçet's disease. Br J Ophthalmol (2003) 1.18
Use of the Megasoft Bandage Lens for treatment of complications after trabeculectomy. Am J Ophthalmol (1990) 1.18
Effects of C-1 on the size of soluble immune aggregates and on their processing by macrophages. J Immunol (1979) 1.15
Macrophages in the retina of normal Lewis rats and their dynamics after injection of lipopolysaccharide. Invest Ophthalmol Vis Sci (1996) 1.15
Endotoxin-induced uveitis in the rat. The significance of intraocular interleukin-6. Invest Ophthalmol Vis Sci (1992) 1.14
Molecular cloning of a new angiopoietinlike factor from the human cornea. Invest Ophthalmol Vis Sci (1998) 1.13
The kinetics for binding and catabolism of aggregated IgG by rat peritoneal macrophages. J Immunol (1979) 1.11
Fuchs' heterochromic cyclitis: review of the literature on the pathogenetic mechanisms. Br J Ophthalmol (1994) 1.10
The lifetime cumulative incidence of acute anterior uveitis in a normal population and its relation to ankylosing spondylitis and histocompatibility antigen HLA-B27. Invest Ophthalmol Vis Sci (1991) 1.09
Low mature TGF-beta 2 levels in aqueous humor during uveitis. Invest Ophthalmol Vis Sci (1994) 1.08
Lactoferrin levels in normal human tears. Br J Ophthalmol (1983) 1.08
Comparison of tears and lacrimal gland fluid in the rabbit and guinea pig. Curr Eye Res (1985) 1.07
Analysis of IL-6 levels in human vitreous fluid obtained from uveitis patients, patients with proliferative intraocular disorders and eye bank eyes. Curr Eye Res (1992) 1.06
Serologic evaluation of patients with primary and recurrent ocular toxoplasmosis for evidence of recent infection. Am J Ophthalmol (1999) 1.06
Analysis of local antibody production in the vitreous humor of patients with severe uveitis. Am J Ophthalmol (1991) 1.05
Clearance and glomerular localization of preformed DNP anti-DNP immune complexes. Scand J Immunol (1979) 1.05
HLA typing in birdshot chorioretinopathy. Am J Ophthalmol (1988) 1.03
Humoral and cellular immune responsiveness to human S-antigen in uveitis. Curr Eye Res (1987) 1.03
Aqueous chamber taps in toxoplasmic chorioretinitis. Doc Ophthalmol (1986) 1.03
Analysis of ocular fluids for local antibody production in uveitis. Br J Ophthalmol (1995) 1.02
Polymorphism of tumour necrosis factor-alpha (TNF-alpha) at position -308 in relation to ankylosing spondylitis. Clin Exp Immunol (1994) 1.02
Serological and polymerase chain reaction-based analysis of aqueous humour samples in patients with AIDS and necrotizing retinitis. AIDS (1996) 1.01
Clinical analysis of Fuchs' heterochromic cyclitis. Doc Ophthalmol (1991) 1.00
Aetiology of uveitis in Sierra Leone, west Africa. Br J Ophthalmol (1996) 0.99
Inhibition of hemolytic complement activity by lactoferrin in tears. Exp Eye Res (1982) 0.99
Presence of Salmonella and Campylobacter spp. in wild small mammals on organic farms. Appl Environ Microbiol (2006) 0.99
Uveitis and diabetes mellitus. Am J Ophthalmol (1988) 0.98
Analysis of interleukin-6 in endotoxin-induced uveitis. Invest Ophthalmol Vis Sci (1991) 0.98
Cyclosporin in the treatment of severe chronic idiopathic uveitis. Br J Ophthalmol (1990) 0.97
Treatment and prognosis of secondary glaucoma in Fuchs' heterochromic iridocyclitis. Am J Ophthalmol (1993) 0.97
Comparison of enzymes of tears, lacrimal gland fluid and lacrimal gland tissue in the rat. Exp Eye Res (1984) 0.97
Immunohistochemical analysis of iris biopsy specimens from patients with Fuchs' heterochromic cyclitis. Am J Ophthalmol (1990) 0.97
Effect of O-(beta-hydroxyethyl)-rutoside on red cell and platelet functions in man. Bibl Anat (1973) 0.97
Elevated serum IL-8 levels are associated with disease activity in idiopathic intermediate uveitis. Br J Ophthalmol (1998) 0.97
Corneal aldehyde dehydrogenase, glutathione reductase, and glutathione S-transferase in pathologic corneas. Cornea (1993) 0.96
Analysis of corneal aldehyde dehydrogenase patterns in pathologic corneas. Cornea (1993) 0.95
Bilateral cytomegalovirus retinitis in a patient with systemic lupus erythematosus. Br J Ophthalmol (1996) 0.95
Normal rat retina lacks significant numbers of ED2-positive macrophages. Invest Ophthalmol Vis Sci (1999) 0.95
Intraocular anti-Toxoplasma gondii IgA antibody production in patients with ocular toxoplasmosis. Am J Ophthalmol (1999) 0.95
Chemoattractant and neutrophil degranulation activities related to interleukin-8 in vitreous fluid in uveitis and vitreoretinal disorders. Invest Ophthalmol Vis Sci (1993) 0.95
Cytokine mRNA expression during experimental corneal allograft rejection. Exp Eye Res (1996) 0.95
Corneal epithelial permeability after instillation of ophthalmic solutions containing local anaesthetics and preservatives. Curr Eye Res (1988) 0.94
Aqueous flare and cells in Fuchs syndrome. Eye (Lond) (2007) 0.94
Blindness from uveitis in a hospital population in Sierra Leone. Br J Ophthalmol (1994) 0.94
Fuchs' heterochromic iridocyclitis is not associated with ocular toxoplasmosis. Arch Ophthalmol (1992) 0.94
Possible ankylosing spondylitis in acute anterior uveitis. Br J Rheumatol (1983) 0.93
Detection of locally produced antibodies to herpes viruses in the aqueous of patients with acquired immune deficiency syndrome (AIDS) or acute retinal necrosis syndrome (ARN). Curr Eye Res (1990) 0.93
Ivermectin detection in serum of onchocerciasis patients: relationship to adverse reactions. Am J Trop Med Hyg (1995) 0.92
Analysis of aqueous humor immunoglobulin G in uveitis by enzyme-linked immunosorbent assay, isoelectric focusing, and immunoblotting. Invest Ophthalmol Vis Sci (1990) 0.92
Macrophages and MHC class II positive cells in the choroid during endotoxin induced uveitis. Br J Ophthalmol (1997) 0.92
Incidence of ocular side effects of topical beta blockers in the Netherlands. Br J Ophthalmol (2000) 0.92
Neospora caninum and Toxoplasma gondii in brain tissue of feral rodents and insectivores caught on farms in the Netherlands. Vet Parasitol (2011) 0.92
Müller cell-specific autoantibodies in a patient with progressive loss of vision. Invest Ophthalmol Vis Sci (1998) 0.91
Concurrent parasitic infections in onchocerciasis and the occurrence of adverse reactions after ivermectin treatment. Am J Trop Med Hyg (1993) 0.91
Does autoimmunity to S-antigen play a role in Fuchs' heterochromic cyclitis? Br J Ophthalmol (1993) 0.90
Clinical and experimental studies concerning circulating antibodies to corneal epithelium antigens. Doc Ophthalmol (1986) 0.90
Immunity to a corneal antigen in Fuchs' heterochromic cyclitis patients. Invest Ophthalmol Vis Sci (1989) 0.90
Inhibition of C3 deposition on solid-phase bound immune complexes by lactoferrin. Immunology (1985) 0.89
Blind confirmation of Geczy factor in ankylosing spondylitis. Lancet (1985) 0.89
Tumour necrosis factor-induced uveitis in the Lewis rat is associated with intraocular interleukin 6 production. Exp Eye Res (1995) 0.89
Quantitative determination of S-antigen in human ocular tissues, aqueous humour and serum. Curr Eye Res (1986) 0.89
Upregulation of T-bet expression in peripheral blood mononuclear cells during Vogt-Koyanagi-Harada disease. Br J Ophthalmol (2005) 0.89
Systemic anti-tumor necrosis factor antibody treatment exacerbates endotoxin-induced uveitis in the rat. Exp Eye Res (1995) 0.88
Localization and characterization of immunocompetent cells in the human retina. Ocul Immunol Inflamm (2000) 0.88
Enhanced degradation of soluble immune complexes by guinea-pig peritoneal macrophages in the presence of complement. Immunology (1981) 0.88
Alpha-adrenoceptor control of peroxidase secretion from rat lacrimal gland cells in vitro. Exp Eye Res (1982) 0.88
The role of cytokines in corneal immunopathology. Ocul Immunol Inflamm (2001) 0.87
Neutrophil activation in ivermectin-treated onchocerciasis patients. Clin Exp Immunol (1993) 0.87
Humoral autoimmune response against S-antigen and IRBP in ocular onchocerciasis. Invest Ophthalmol Vis Sci (1990) 0.87
Diagnostic assays in cytomegalovirus retinitis: detection of herpesvirus by simultaneous application of the polymerase chain reaction and local antibody analysis on ocular fluid. Br J Ophthalmol (1996) 0.87
HLA-A29 subtypes and birdshot chorioretinopathy. Immunogenetics (1992) 0.87